Disruption Talks by Netguru Ep. 140. Innovate Like Sandoz: Partnerships That Disrupt – with Dan Ma, Head of Innovation & New Commercial Partnerships at Sandoz Germany
Oct 3, 2024
37:01
Are you interested in digital health? Corporate innovation? Or even the future of healthcare?
If you answered yes to any of those questions, this episode is for you. We sat down with Dan, Head of Innovation & New Commercial Partnerships at Sandoz Innovation Lab in Germany, to discuss how Sandoz is pioneering new approaches in patient care through digital health solutions and innovative partnerships.
Dan’s journey from molecular biotechnology to leading cutting-edge digital initiatives will show you how traditional pharmaceutical companies are embracing technology to push boundaries and improve healthcare.
What we have discussed?
– How Sandoz, a generic pharmaceutical company, drives innovation beyond products.
– How they launched the first-ever biosimilar and how they continue to lead with 10 marketed molecules and 24 in development.
– The current status, ePrescriptions, and the future potential of electronic patient records.
– How curiosity, purpose, and collaboration foster "outside-the-box" ideas within the Sandoz Innovation Lab.
– The partnership with Careanimation and its impact on improving health literacy and medication compliance with Apoclip.
– Why market adoption can be slow and how smart risk-taking can accelerate the process.
If you answered yes to any of those questions, this episode is for you. We sat down with Dan, Head of Innovation & New Commercial Partnerships at Sandoz Innovation Lab in Germany, to discuss how Sandoz is pioneering new approaches in patient care through digital health solutions and innovative partnerships.
Dan’s journey from molecular biotechnology to leading cutting-edge digital initiatives will show you how traditional pharmaceutical companies are embracing technology to push boundaries and improve healthcare.
What we have discussed?
– How Sandoz, a generic pharmaceutical company, drives innovation beyond products.
– How they launched the first-ever biosimilar and how they continue to lead with 10 marketed molecules and 24 in development.
– The current status, ePrescriptions, and the future potential of electronic patient records.
– How curiosity, purpose, and collaboration foster "outside-the-box" ideas within the Sandoz Innovation Lab.
– The partnership with Careanimation and its impact on improving health literacy and medication compliance with Apoclip.
– Why market adoption can be slow and how smart risk-taking can accelerate the process.